Mawer Investment Management’s Twist Bioscience TWST Stock Holding History

Mawer Investment Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Buy	+99,251	New	+$6.46M	0.07%	109

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Mawer Investment Management's TWST Position: Q2 2026 in Review

Mawer Investment Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 99,251 shares worth $10.2M. The stake represents 0.07% of the portfolio and ranks #109 among its holdings.

123 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Mawer Investment Management held 99,251 shares of Twist Bioscience worth $10.2M as of Q2 2026.
Twist Bioscience was a new Mawer Investment Management position in Q2 2026.
Twist Bioscience made up 0.07% of Mawer Investment Management's portfolio in Q2 2026, its #109 holding.
123 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Mawer Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.